No abstract available.
Drug Therapy* ; Stomach Neoplasms*

No abstract available.
Plasma Exchange* ; Plasma*

No abstract available.
Gaucher Disease*

BACKGROUND: We evaluated 1) the sequential changes of angiotensin-converting enzyme (ACE) mRNA expression in lung (main site for circulating ACE synthesis) and left ventricle, and 2) whether such expression is modified by ACE inhibitor or angiotensin II receptor blocker treatment after acute myocardial infarction (MI) in rats. METHODS: Placebo, captopril (2 g/liter drinking water) or TCV-116 (10 mg/kg/day gavage) was administered 3 days before left coronary occlusion and continued for 6 weeks. At 1, 3 and 6 weeks after operation, hemodynamic measurement was performed and pulmonary and myocardial ACE mRNA expression was analyzed by quantitative RT-PCR using rcRNA as an internal standard. RESULTS: Mean BP and LVEDP increased in untreated rats compared with captopril- and TCV-116-treated rats (post-MI 6week, p<0.05). Pulmonary ACE mRNA increased in acute phase (post-MI 1 week, max. 1.4 fold, p<0.05 vs. pre-MI) and returned to pre-MI value thereafter. In contrast, cardiac ACE mRNA expression showed slightly decreasing tendency in acute phase, and was increased up to 1.6 fold in chronic phase after MI (post-MI 3 and 6weeks, p<0.05 vs. pre-MI). No changes in pulmonary ACE gene expression were found with RAS blockade. However, in acute phase after MI, cardiac ACE mRNA increased with both captopril and TCV-116 treatment (post-MI 24hour and 1week, max. 2 fold, p<0.05 vs. untreated group). CONCLUSION: 1) In contrast to the pulmonary ACE mRNA that is activated in acute phase, the cardiac ACE mRNA is activated in chronic phase after MI. 2) RAS blockade does not affect the change of pulmonary ACE expression, but modulate the change of cardiac ACE expression after MI.
Animals ; Captopril ; Coronary Occlusion ; Drinking ; Gene Expression* ; Heart Ventricles ; Hemodynamics ; Lung* ; Myocardial Infarction* ; Myocardium* ; Peptidyl-Dipeptidase A ; Rats ; Receptors, Angiotensin ; RNA, Messenger

No abstract available.
Female ; Ovary*

No abstract available.

Endovascular aneurysm repair (EVAR) has been a revolutionary development in the treatment of abdominal aortic aneurysms (AAAs) since its introduction in the early 1990s. The result of the two randomized controlled trials comparing EVAR versus open repair for the treatment of AAAs has provided some insight to the advantages and limitations of EVAR technology. Endoleaks continue to be a challenge for EVAR and most endoleaks can now be successfully managed by endovascular techniques. Fenestrated and branched stent-graft technology is increasingly applied to patients with complex AAA anatomies. This paper outlines some of the concepts and discusses the controversies and challenges facing clinicians involved in EVAR today and in the future.
Aneurysm ; Aortic Aneurysm, Abdominal ; Endoleak ; Endovascular Procedures ; Humans

Transarterial radioembolization (TARE) with yttrium 90 (⁹⁰Y), an intra-arterial procedure performed by interventional radiologists, has begun being utilized in managing hepatocellular carcinoma (HCC) in Korea. There are two available TARE products: glass and resin microspheres with different physical characteristics. All patients undergoing TARE must be assessed with clinical examination and laboratory tests as well as a thorough angiographic evaluation. TARE is safe and effective in the treatment of unresectable HCC, as it has longer time-to-progression, greater ability to downsize tumors for liver transplantation, less post-embolization syndrome, and shorter hospitalization compared with chemoembolization. TARE can also serve as an alternative to ablation, surgical resection, portal vein embolization, and sorafenib. The utility of TARE continues to expand with new insights in interventional oncology.
Carcinoma, Hepatocellular* ; Glass ; Hospitalization ; Humans ; Korea ; Liver Transplantation ; Microspheres ; Portal Vein ; Yttrium

No abstract available.
Hematuria* ; Humans ; Mass Screening* ; Urinary Bladder Neoplasms* ; Urinary Bladder*

PURPOSE: This study was done to investigate the factors that influence non-combat soldiers' suicidal ideation. METHODS: The participants of survey were 302 of soldiers in Y and H city. The data were collected from Aug. 5 to 8, 2008 in H city and Oct. 25 to 30, 2009 in Y city. The instruments were the SRI (Stress Response Inventory) developed by Ko, Park, & Kim (2000), SDS (Self-Rating Depression Scale), developed by Zung (1965) and SSI (Scale for Suicidal Ideation) developed by Beck (1979). The data were analyzed using SPSS 12.0. RESULTS: The mean score for the SRI, SDS and SSI were 15.71+/-19.81, 32.02+/-9.67 and 1.34+/-2.74 respectively. There were positive correlations between the SRI and SDS (r=.763), SRI and SSI (r=.583), SDS and SSI (r=.575). Stress, depression, age, and educational level accounted for 41% of the variance in suicidal ideation. CONCLUSION: The results of this study indicates that soldiers' suicidal ideation is related to stress, depression, age, and educational level and that there is a need to develop programs which focus on stress and depression management.
Depression ; Humans ; Military Personnel* ; Suicidal Ideation* ; Suicide